Sign inJoin waitlistJoin the waitlist

Thomas Wisniewski

Program Director, Alzheimer's Disease Research Center · NYU Grossman School of Medicine

Credentials: · · · ·

History

Alzheimer's Disease Research Center · NYU Grossman School of Medicine
Present
Department of Neurology · NYU Grossman School of Medicine
Present
Center for Cognitive Neurology · NYU Grossman School of Medicine
Present

Neuropathology
New York Presbyterian Hospital
1988–1990
Neurology
NYU Langone Hospitals
1984–1988
University of London
1979–1983

Research

Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
Review · Journal of Neuropathology & Experimental Neurology · 2012 · 1,666 citations
Clearance systems in the brain-implications for Alzheimer disease
Review · Nature Reviews Neurology · 2015 · 1,365 citations
Primary age-related tauopathy (PART): a common pathology associated with human aging
Acta Neuropathologica · 2014 · 1,220 citations

Orrin Devinsky
25 papers
Arjun Masurkar
23 papers
Arline Faustin
19 papers · 1 as a fellow
Jennifer Frontera
17 papers
Martin Sadowski
17 papers · 2 as a resident
BR
Barry Reisberg
15 papers
Laura Balcer
13 papers
Steven Galetta
12 papers
Ariane Lewis
11 papers
Julie Schneider
10 papers
TB
Thomas Beach
10 papers
Ann McKee
9 papers

Grants

Alzheimer's Disease Research Center
National Institute on Aging · P30
Contact PI · $23.6M · New York University School of Medicine
2020–2031
The Role of Immune Deregulation and NGF Dysmetabolism in the Development of Alzheimer Disease in Individuals with Down Syndrome
National Institute on Aging · R01
PI · $3.2M · University of California-Irvine
2024–2029
Multi-Scale and Multi-Modality Imaging of Neuropathology in VCID
National Institute of Neurological Disorders and Stroke · U24
PI · $6.6M · New York University School of Medicine
2023–2028
ARIA Pathophysiology Characterized by in vivo Neuroimaging, Plasma Biomarkers and Post-Mortem Proteomics
National Institute of Neurological Disorders and Stroke · U24
Contact PI · $3.3M · New York University School of Medicine
2025–2027

Clinical trials

A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Site PI · Recruiting · Phase 2, Phase 3
Washington University School of Medicine
2024–2034